Found: 35
Select item for more details and to access through your institution.
Cover Image, Volume 22, Issue 12.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 1, doi. 10.1111/dom.14250
- By:
- Publication type:
- Article
Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2248, doi. 10.1111/dom.14208
- By:
- Publication type:
- Article
Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2493, doi. 10.1111/dom.14175
- By:
- Publication type:
- Article
Short‐term intestinal lipase inhibition in normal‐weight individuals does not affect postprandial peptide YY<sub>3‐36</sub> and glucagon‐like peptide‐1 levels, hunger or satiety.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2499, doi. 10.1111/dom.14182
- By:
- Publication type:
- Article
Machine‐learning–based early prediction of end‐stage renal disease in patients with diabetic kidney disease using clinical trials data.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2479, doi. 10.1111/dom.14178
- By:
- Publication type:
- Article
Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2468, doi. 10.1111/dom.14177
- By:
- Publication type:
- Article
Dietary fibre intake in childhood or adolescence and subsequent health outcomes: A systematic review of prospective observational studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2460, doi. 10.1111/dom.14176
- By:
- Publication type:
- Article
A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2227, doi. 10.1111/dom.14196
- By:
- Publication type:
- Article
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2451, doi. 10.1111/dom.14174
- By:
- Publication type:
- Article
Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2437, doi. 10.1111/dom.14173
- By:
- Publication type:
- Article
Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2427, doi. 10.1111/dom.14172
- By:
- Publication type:
- Article
Role of exendin‐4 in the Gila monster: Further lessons regarding human oral glucagon‐like peptide‐1 therapy?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2509, doi. 10.1111/dom.14171
- By:
- Publication type:
- Article
COVID‐19, ketoacidosis and new‐onset diabetes: Are there possible cause and effect relationships among them?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2507, doi. 10.1111/dom.14170
- By:
- Publication type:
- Article
Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2417, doi. 10.1111/dom.14169
- By:
- Publication type:
- Article
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2408, doi. 10.1111/dom.14168
- By:
- Publication type:
- Article
Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA‐REG OUTCOME trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2335, doi. 10.1111/dom.14158
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptying.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2504, doi. 10.1111/dom.14166
- By:
- Publication type:
- Article
Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2209, doi. 10.1111/dom.14165
- By:
- Publication type:
- Article
Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2384, doi. 10.1111/dom.14164
- By:
- Publication type:
- Article
Efficacy and safety of polyethylene glycol loxenatide as add‐on to metformin in patients with type 2 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3b trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2375, doi. 10.1111/dom.14163
- By:
- Publication type:
- Article
The effect of a low glycaemic index diet on reducing day‐long glycaemia in healthy young adults: A randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2398, doi. 10.1111/dom.14167
- By:
- Publication type:
- Article
Effects of insulin degludec and insulin glargine U300 on glycaemic stability in individuals with type 1 diabetes: A multicentre, randomized controlled crossover study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2356, doi. 10.1111/dom.14161
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and major adverse limb events: A trial‐level meta‐analysis including 51 713 individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2348, doi. 10.1111/dom.14159
- By:
- Publication type:
- Article
Assessing the cost‐effectiveness of sodium–glucose cotransporter‐2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real‐world evidence.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2364, doi. 10.1111/dom.14162
- By:
- Publication type:
- Article
Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3‐year follow‐up of the Qatar study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2287, doi. 10.1111/dom.14153
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and tolerability of single and multiple doses of janagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, in Chinese people with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2316, doi. 10.1111/dom.14156
- By:
- Publication type:
- Article
Genetic variation in lean body mass, changes of appetite and weight loss in response to diet interventions: The POUNDS Lost trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2305, doi. 10.1111/dom.14155
- By:
- Publication type:
- Article
Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2295, doi. 10.1111/dom.14154
- By:
- Publication type:
- Article
Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10‐year diabetes cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2325, doi. 10.1111/dom.14157
- By:
- Publication type:
- Article
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150
- By:
- Publication type:
- Article
The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2267, doi. 10.1111/dom.14149
- By:
- Publication type:
- Article
Effect of cilostazol on carotid plaque volume measured by three‐dimensional ultrasonography in patients with type 2 diabetes: The FANCY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2257, doi. 10.1111/dom.14147
- By:
- Publication type:
- Article
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2241, doi. 10.1111/dom.14049
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2207, doi. 10.1111/dom.13723
- Publication type:
- Article